Level Four Advisory Services’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
RCM
FAM
Level Four Advisory Services's PCVX Position: Q3 2023 in Review
Level Four Advisory Services sold out of Vaxcyte (PCVX) in Q3 2023, closing a stake of 9,173 shares — an estimated $458K sold.
Level Four Advisory Services first reported a position in PCVX in Q2 2023 and held it in 1 quarter. The position peaked at $458K in Q2 2023. 202 funds tracked by Wall St. Rank hold PCVX as of Q3 2023.
- Level Four Advisory Services reported no remaining Vaxcyte position as of Q3 2023 after selling out during the quarter.
- Level Four Advisory Services sold 9,173 Vaxcyte shares in Q3 2023, an estimated $458K.
- Level Four Advisory Services first reported a position in Vaxcyte in Q2 2023 and held it in 1 quarter.
- Level Four Advisory Services's Vaxcyte position peaked at $458K in Q2 2023.
- 202 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2023.
Based on Level Four Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.